Psychotherapy in the Managed Care Health Market

  title={Psychotherapy in the Managed Care Health Market},
  author={A. Stone},
  journal={Journal of Psychiatric Practice},
  • A. Stone
  • Published 2001
  • Psychology, Medicine
  • Journal of Psychiatric Practice
The author considers the future of psychotherapy in the managed care health market. He focuses on two interrelated questions. How can the efficacy of psychotherapy be scientifically demonstrated? Can psychotherapy meet the standards of cost-effectiveness set by health plans? He notes that efficacy is not enough in the managed care market, in which health plans also focus on the rational allocation of resources and economies of scale. The author then turns to the question of whether the doctor… Expand
Toward a Hippocratic Psychopharmacology
  • S. Ghaemi
  • Medicine
  • Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 2008
Current psychopharmacology is aggressive and non-Hippocratic: symptom-based, rather than disease oriented; underemphasizing drug risks; and prone to turning symptoms into diagnoses. Expand
Future psychologists' perceptions of managed care
of a Dissertation Submitted to the Graduate Studies Office of The University of Southern Mississippi in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy


The effectiveness of psychotherapy. The Consumer Reports study.
  • M. Seligman
  • Psychology, Medicine
  • The American psychologist
  • 1995
It is concluded that the Consumer Reports survey complements the efficacy method, and that the best features of these two methods can be combined into a more ideal method that will best provide empirical validation of psychotherapy. Expand
National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments.
There was limited evidence of the specific effectiveness of interpersonal psychotherapy and none for cognitive behavior therapy, but Superior recovery rates were found for both interpersonal Psychotherapy and imipramine plusclinical management, as compared with placebo plus clinical management. Expand
The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program.
Therapeutic alliance was found to have a significant effect on clinical outcome for both psychotherapies and for active and placebo pharmacotherapy, and ratings of therapist contribution to the alliance and outcome were not significantly linked. Expand
Impact of perfectionism and need for approval on the brief treatment of depression: the National Institute of Mental Health Treatment of Depression Collaborative Research Program revisited.
DAS Perfectionism had consistently significant negative relationships with all the outcome measures in all four treatment conditions, and there were no significant interactions between the two DAS factors and the four types of brief treatment. Expand
Making the case for psychoanalytic therapies in the current psychiatric environment.
Several steps that might lend the psychoanalytic therapies greater credibility are proposed: define the distinguishing features, identify clear indications and contraindications, and systematically collect case histories of successfully treated mentally ill (diagnosable) patients. Expand
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
Although about half of patients with chronic forms of major depression have a response to short-term treatment with either nefazodone or a cognitive behavioral-analysis system of psychotherapy, the combination of the two is significantly more efficacious than either treatment alone. Expand
Trends in office-based psychiatric practice.
In the decade between 1985 and 1995, visits in office-based psychiatry became shorter, less often included psychotherapy, and more often included a medication prescription. Expand
Science, Politics, and the Politics of Science: The Use and Misuse of Empirically Validated Treatment Research
This paper examines the possible long-term negative effects of the Empirically Validated Treatment (EVT) movement. It is suggested that the EVT approach runs the risk of reducing the quality ofExpand
The psychiatric patient's right to effective treatment: implications of Osheroff v. Chestnut Lodge.
  • G. Klerman
  • Psychology, Medicine
  • The American journal of psychiatry
  • 1990
Although Osheroff v. Chestnut Lodge never reached final court adjudication, the case generated widespread discussion in psychiatric, legal, and lay circles and the author suggests that this case involves the proposed right of the patient to effective treatment and that treatmentswhose efficacy has been demonstrated have priority over treatments whose efficacy has not been established. Expand
The Future of Physicians' Time
The virtual single payer system has resulted in what I call the hamster model of physician reimbursement, making the situation of U.S. physicians similar to that of physicians in Germany and Canada. Expand